Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

A Discrete-Choice Experiment to Assess Patient Preferences for Long-Acting Injectable Treatments in Opioid Use Disorder in Australia, Finland, Germany, and Italy

Bibliographic Data

ID15442199
AuthorsMadhulika Kabra (0000-0003-3315-9782, Indivior (United Kingdom), corresponding author), Madhusudan Kabra, Shehzad Ali (0000-0002-8042-3630, Western University), Mona Sadeghian (Indivior (United Kingdom)), Maithreyi Thamattoor, Tim MacDonald (Griffith University), Nils Lenuweit (Orthopädische Praxis), Ulriika Sundell (358 (Finland)), Michela Moscone (Agenzia Sanitaria Regionale Abruzzo), Heidi Holmström Larm (Indivior (United States)), Radha Sharma (0009-0007-8173-9366, Taylor College and Seminary)
Year2025
Publication date2025-12-09
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueInternational Journal of Mental Health and Addiction (JOURNAL)
Journal identifiersISSN: 1557-1874 • E-ISSN: 1557-1882
PublisherSpringer Science+Business Media (PUBLISHER • DE)
DOI10.1007/s11469-025-01605-z
OpenAlexW4417164812
LanguageEN
References cited50

Opioid use disorder (OUD) is characterized by dependence on opioids along with an inability to manage their use, leading to behaviors that impact patients’ lives. Long-acting injectable (LAI) treatments for OUD offer benefits compared with short-acting options. This study assessed treatment preferences of patients with OUD in Australia, Finland, Germany, and Italy regarding attributes of LAI buprenorphine. Based on a literature review and consultations, six attributes of OUD treatments were included in a discrete choice experiment study, conducted online. Participants who completed the survey ( n = 317) were aged 37.2 ± 12 years, with 54% male and 36% having prior LAI experience. Higher preferences were expressed for less frequent injections, higher chance of staying off unprescribed opioids after six months of treatment, treatment through general practitioners or specialized centers, reduced withdrawal symptoms, earlier onset of treatment benefits, and a shorter timeframe to feel stable. Patients valued independence, fewer clinic visits, interpersonal relationships, and achieving sobriety. In summary, patients preferred LAI treatments with improved profiles on frequency, withdrawals, onset, and opioid abstinence, along with reduced stigma, fewer visits, and sustained benefits

Extended release · Health psychology · Interpersonal communication · Opiate Substitution Treatment · Opioid · Opioid use disorder · HIV, Drug Use, Sexual Risk · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes · Rehabilitation

  • Mortality risk during and after opioid substitution treatment

    Open Access•Luis Sordo, Gregorio Barrio et al.•BMJ•2017

  • Global patterns of opioid use and dependence

    Open Access•Louisa Degenhardt, J Grebely et al.•The Lancet•2019

  • Opiate substitution treatment and HIV transmission in people who inject drugs

    Open Access•G J MacArthur, S Minozzi et al.•BMJ•2012

  • The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017

    Open Access•Curtis Florence, Feijun Luo et al.•Drug and Alcohol Dependence•2021

  • Content analysis and thematic analysis

    Open Access•Mojtaba Vaismoradi, Hannele Turunen et al.•Nursing & Health Sciences•2013

  • An international comparative policy analysis of opioid use disorder treatment in primary care across nine high-income jurisdictions

    Open Access•Kellia Chiu, Saloni Pandya et al.•Health Policy•2024

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae